Fusen Pharmaceutical Co., Ltd.(HK:1652)
HK$0.90-0.03 (-3.23%)
HK:1652
Fusen Pharmaceutical Co., Ltd. financials statements
HK$0.90
At close:-0.03 (-3.23%)
Want to see HK:1652 full AI Analyst Report?
Fusen Pharmaceutical Co., Ltd. (1652) Income Statement
0 Followers
Fusen Pharmaceutical Co., Ltd. Income Statement
Last quarter (Q2 2026), Fusen Pharmaceutical Co., Ltd.'s total revenue was ¥114.18M, a decrease of 41.84% from the same quarter last year. In Q2, Fusen Pharmaceutical Co., Ltd.'s net income was ¥-13.69M. See Fusen Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 273.37M | ¥ 326.03M | ¥ 565.61M | ¥ 491.76M | ¥ 385.66M | |
| ¥ 109.79M | ¥ 162.64M | ¥ 299.51M | ¥ 225.02M | ¥ 211.13M | |
| ¥ 111.51M | ¥ 230.15M | ¥ 279.49M | ¥ 186.41M | ¥ 146.65M | |
| Depreciation and Amortization | ¥ 37.42M | ¥ 41.71M | ¥ 35.80M | ¥ 34.16M | ¥ 23.79M |
| ¥ 11.55M | ¥ -25.46M | ¥ 18.93M | ¥ 49.90M | ¥ 55.82M | |
| ¥ -1.72M | ¥ -67.51M | ¥ 20.02M | ¥ 15.74M | ¥ 52.14M | |
| ¥ -5.88M | ¥ -122.94M | ¥ -49.46M | ¥ -74.75M | ¥ -28.35M | |
| ¥ -7.60M | ¥ -190.45M | ¥ -29.45M | ¥ -30.99M | ¥ 23.79M | |
| ¥ -11.78M | ¥ -188.78M | ¥ -36.28M | ¥ -34.65M | ¥ 16.64M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ -0.02 | ¥ -0.26 | ¥ -0.05 | ¥ -0.05 | ¥ 0.02 |
| Diluted EPS | ¥ -0.02 | ¥ -0.26 | ¥ -0.05 | ¥ -0.05 | ¥ 0.02 |
| Weighted Average Shares Outstanding | 739.30M | 739.98M | 725.54M | 756.07M | 769.62M |
| Weighted Average Shares Outstanding (Diluted) | 739.30M | 739.98M | 752.06M | 756.07M | 770.31M |
Currency in CNY

